"We provide a full scale of gastroenterology services and procedures, including care for liver disease, infusion, weight loss."

During the past decade, Caprock Gastro Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Caprock Gastro Research" are "Ulcerative Colitis" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Caprock Gastro Research" in a lesser frequency.

Most popular intervention types in "Caprock Gastro Research" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Guselkumab" (2 trials), "Placebo" (2 trials), "AMT-101 (oral)" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Caprock Gastro Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Caprock Gastro Research". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Caprock Gastro Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Caprock Gastro Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".